BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
-9.76%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$16.2B
AUM Growth
+$16.2B
Cap. Flow
+$164M
Cap. Flow %
1.01%
Top 10 Hldgs %
86.32%
Holding
116
New
17
Increased
25
Reduced
19
Closed
6

Top Buys

1
ALXN
Alexion Pharmaceuticals Inc
ALXN
$45.1M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
$44.4M
3
KOD icon
Kodiak Sciences
KOD
$25.1M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
$22M
5
ALLK
Allakos
ALLK
$17.6M

Top Sells

1
BOLD
Audentes Therapeutics, Inc
BOLD
$48.2M
2
EXAS icon
Exact Sciences
EXAS
$42.9M
3
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
$11.4M
4
ADPT icon
Adaptive Biotechnologies
ADPT
$10.3M
5
NXTC icon
NextCure
NXTC
$8.45M

Sector Composition

1 Healthcare 98.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NGM
76
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$3.08M 0.02% 250,000 – –
ORTX
77
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$3.06M 0.02% 405,702 – –
KRTX
78
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3.02M 0.02% +41,976 New +$3.02M
ARAV
79
DELISTED
Aravive, Inc. Common Stock
ARAV
$2.8M 0.02% 486,333 +53,000 +12% +$305K
MRKR icon
80
Marker Therapeutics
MRKR
$12M
$2.79M 0.02% 1,470,198 -29,802 -2% -$56.6K
CRNX icon
81
Crinetics Pharmaceuticals
CRNX
$2.92B
$2.57M 0.02% 175,000 – –
GLPG icon
82
Galapagos
GLPG
$2.07B
$2.56M 0.02% 13,072 – –
XLRN
83
DELISTED
Acceleron Pharma Inc.
XLRN
$2.43M 0.01% +27,000 New +$2.43M
GBT
84
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.4M 0.01% +47,000 New +$2.4M
HARP
85
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$2.37M 0.01% 204,467 -9,818 -5% -$114K
MTNB icon
86
Matinas BioPharma
MTNB
$10.1M
$2.25M 0.01% 3,754,221 +1,121,873 +43% +$673K
APLT icon
87
Applied Therapeutics
APLT
$71M
$2.16M 0.01% +65,934 New +$2.16M
VKTX icon
88
Viking Therapeutics
VKTX
$3.04B
$1.99M 0.01% 425,000 – –
BLUE
89
DELISTED
bluebird bio
BLUE
$1.84M 0.01% 40,000 – –
DNLI icon
90
Denali Therapeutics
DNLI
$2.23B
$1.84M 0.01% +104,900 New +$1.84M
RCUS icon
91
Arcus Biosciences
RCUS
$1.13B
$1.69M 0.01% 121,534 – –
VYNE icon
92
VYNE Therapeutics
VYNE
$8.16M
$1.68M 0.01% 625,345 -74,655 -11% -$200K
NTLA icon
93
Intellia Therapeutics
NTLA
$1.22B
$1.57M 0.01% 128,538 – –
LPTX icon
94
Leap Therapeutics
LPTX
$12M
$1.55M 0.01% 978,454 – –
IMTX icon
95
Immatics
IMTX
$619M
$1.53M 0.01% +150,000 New +$1.53M
DRNA
96
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.51M 0.01% +81,935 New +$1.51M
BLCM
97
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.17M 0.01% 249,123 -2,428,695 -91% -$11.4M
GTHX
98
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$970K 0.01% 88,026 -39,210 -31% -$432K
AUTL
99
Autolus Therapeutics
AUTL
$399M
$939K 0.01% 156,773 – –
GLMD icon
100
Galmed Pharmaceuticals
GLMD
$6.96M
$746K ﹤0.01% 215,594 – –
1 2 3
4
5